Chief Regulatory Officer · NEUROCRINE BIOSCIENCES INC · Common Stock
Side
SELL
Value
$354K
Shares
2,261
Price
$156.71
Executed
May 29, 2026
Disclosed
Jun 2, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
May 29 executedJun 2, 2026 disclosed
NBIX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Delaet Ingrid filed this Form 4 reporting a open-market sale of NBIX on May 29, 2026. It became public on Jun 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Regulatory Officer
Delaet Ingridcik:0001965808
Issuer
NEUROCRINE BIOSCIENCES INCcik:0000914475
Revision history · 0
No field has changed since this record was first ingested.
